Cargando…
Focal Cryo-Immunotherapy with Intratumoral IL-12 Prevents Recurrence of Large Murine Tumors
SIMPLE SUMMARY: Focal cryoablation is an FDA-approved minimally-invasive treatment for certain kidney, colon, lung, breast, and prostate cancers. However, it is difficult to ensure complete tumor destruction after ablation, and therefore, tumor recurrence rates can be as high as 80%. In order to imp...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137033/ https://www.ncbi.nlm.nih.gov/pubmed/37190138 http://dx.doi.org/10.3390/cancers15082210 |